carlisle & Associates
generic drug updates News contact carlisle medical
news
generic drug updates
Generic Opana ER® Launches
Released: 01/15/2013
By: Mike Partridge, RPh

On January 7, 2013, Global Pharmaceutical received final FDA approval for and commenced shipping the generic equivalent for Endo’s branded product, Opana ER® (oxymorphone HCL) tablets. Opana ER® had estimated total U.S. annual sales of approximately $25 million.

Opana is an opioid agonist indicated for the relief of moderate to severe pain in patients requiring continuous around the clock opioid treatment for an extended period of time


<<Back
 
Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
 
 
 
 
 
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer